US Stock MarketDetailed Quotes

ABEO Abeona Therapeutics

Watchlist
  • 5.9550
  • +0.3850+6.91%
Trading Jan 2 15:23 ET
258.87MMarket Cap-2.90P/E (TTM)

Abeona Therapeutics Key Stats

Abeona Therapeutics Q3 2024 Earnings Date

Currency:USDNov 14, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
EPS
-0.39
-0.63
-0.24
Miss Est.
+19.59%
-31.25%
-63.25%
Net Income
--
-30.27M
--
-155.74%
Buy

Dec 31, 2024

Abeona Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 125.000K--
--2024/Q4-- / 83.330K--
Nov 14, 20242024/Q30.000 / 83.330K--
Aug 12, 20242024/Q20.000 / 83.330K--
May 15, 20242024/Q10.000 / 125.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 125.000K--
--2024/Q4-- / 83.330K--
Nov 14, 20242024/Q30.000 / 83.330K--
Aug 12, 20242024/Q20.000 / 83.330K--
May 15, 20242024/Q10.000 / 125.000K--

Unlock Free Earnings Estimates

Abeona Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data